| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/10/2013 | US8529906 Compositions for inducing immune responses |
| 09/10/2013 | US8529905 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/10/2013 | US8529904 Antigenic peptide comprising sequenc simimlarity to wilm's tumor-1 gene a nd gata-1 transcription factor for use as targeting tools in treatment of cell proliferative disorders; tissue targeted therapy |
| 09/10/2013 | US8529903 Anti-RhD monoclonal antibodies |
| 09/10/2013 | US8529902 for promoting proliferation and/or differentiation of B cells involved in cancers and autoimmune disorders; animal models; genetic engineering |
| 09/10/2013 | US8529901 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label |
| 09/10/2013 | US8529900 Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer |
| 09/10/2013 | US8529899 Human growth hormone immunoglobulin fusion proteins |
| 09/10/2013 | US8529898 Activatable binding polypeptides and methods of identification and use thereof |
| 09/10/2013 | US8529897 Inflammation-regulating compositions and methods |
| 09/10/2013 | US8529896 Anti-BST2 antibody |
| 09/10/2013 | US8529895 Method for suppressing the development of graft-versus-host-disease by administering interleukin 6 receptor antibodies |
| 09/10/2013 | US8529894 Methods of reducing inflammation in cardiomyopathy |
| 09/10/2013 | US8529893 Methods for treating IFN-γ mediated diseases using human anti-IFN-γ neutralizing antibodies as selective IFN-gamma pathway inhibitors |
| 09/10/2013 | US8529891 Inhibitors of extracellular HSP90 |
| 09/10/2013 | US8529884 Using vector transformation to express herpes simple-1 viral gene sequences in cells; inducing immune response to pathogen attack |
| 09/10/2013 | US8529881 Peptides for active anti-cytokine immunization |
| 09/10/2013 | DE202013005130U1 Influenza Virus Reassortierung Influenza virus reassortment |
| 09/10/2013 | CA2693296C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 09/10/2013 | CA2673477C Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 09/10/2013 | CA2610987C Stabilizer for protein preparation comprising meglumine and use thereof |
| 09/10/2013 | CA2610919C Hepatitis c virus nucleic acid vaccine |
| 09/10/2013 | CA2608058C Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| 09/10/2013 | CA2605015C Compositions and assays to detect influenza virus a and b nucleic acids |
| 09/10/2013 | CA2593714C Survivin peptide vaccine |
| 09/10/2013 | CA2573192C Variant fc regions |
| 09/10/2013 | CA2561914C Microfluidized oil-in-water emulsions and vaccine compositions |
| 09/10/2013 | CA2544483C Soluble tcr fusion molecules and methods of use |
| 09/10/2013 | CA2529056C Combinations of tumor-associated antigens in compositions for various types of cancers |
| 09/10/2013 | CA2458627C Human cdr-grafted antibody and antibody fragment thereof |
| 09/10/2013 | CA2456247C Use of il-18 inhibitors in hypersensitivity disorders |
| 09/10/2013 | CA2451566C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 09/10/2013 | CA2427340C Cyp1b1 nucleic acids and methods of use |
| 09/10/2013 | CA2413237C Alteration of cell membrane for new functions |
| 09/10/2013 | CA2392527C Hbv/hcv virus-like particle |
| 09/10/2013 | CA2376693C Immunological control of .beta.-amyloid levels in vivo |
| 09/10/2013 | CA2338194C Equine system for non-surgical artificial insemination |
| 09/10/2013 | CA2331789C Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 09/10/2013 | CA2272245C Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies |
| 09/08/2013 | CA2770773A1 Novel method for analyzing circulating tumor cells of a patient for the presence of metastasis-initiating cells |
| 09/06/2013 | WO2013131010A2 Function of chemokine receptor ccr8 in melanoma metastasis |
| 09/06/2013 | WO2013131001A1 ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF |
| 09/06/2013 | WO2013130981A1 Human antibodies to clostridium difficile toxins |
| 09/06/2013 | WO2013130905A1 Antibodies to matrix metalloproteinase 9 |
| 09/06/2013 | WO2013130882A1 Compositions and methods for treating cancer |
| 09/06/2013 | WO2013130821A1 Methods and compositions for injection delivery |
| 09/06/2013 | WO2013130814A1 Novel prodrug containing molecule compostions and their uses |
| 09/06/2013 | WO2013130577A2 Compositions and methods for the treatment of migraine |
| 09/06/2013 | WO2013130565A1 Neutralizing antibody for epstein barr virus associated disease |
| 09/06/2013 | WO2013130462A1 Antibody production methods |
| 09/06/2013 | WO2013130422A1 Compositions and methods for treating mitochondrial diseases |
| 09/06/2013 | WO2013130412A1 Anti-immune complex antibodies |
| 09/06/2013 | WO2013130132A1 Influenza hemagglutinin variants |
| 09/06/2013 | WO2013130078A1 Antibodies to matrix metalloproteinase 9 |
| 09/06/2013 | WO2013129953A1 Vaccine against strangles of the equidae |
| 09/06/2013 | WO2013129936A1 Use of an antibody and a particulate immunomodulator in therapy |
| 09/06/2013 | WO2013129935A1 Use of a particulate immunomodulator in cancer therapy |
| 09/06/2013 | WO2013128441A1 Methods and compositions for treating psc(primary sclerosing cholangitis) or pbc (primary biliary cirrhosis) with anti-cd3 immune molecule therapy |
| 09/06/2013 | WO2013128424A1 Vaccine for prophylaxis or treatment of an allergen-driven and/or a chronic airways disease |
| 09/06/2013 | WO2013128381A1 Combined therapy of alpha-1-antitrypsin and temporal t-cell depletion for preventing graft rejection |
| 09/06/2013 | WO2013127981A1 Protease inhibitors for treating trichomonas gallinae infections |
| 09/06/2013 | WO2013127976A1 Method for the preparation of dendritic cell vaccines |
| 09/06/2013 | WO2013126962A1 Therapeutic and diagnostic agents |
| 09/06/2013 | WO2013105105A3 Novel viral vaccine compositions and methods for preparing such vaccines |
| 09/06/2013 | WO2012177924A3 Influenza virus mutants and uses therefor |
| 09/06/2013 | CA2850962A1 Influenza hemagglutinin variants |
| 09/05/2013 | US20130231466 Methods for detecting th1 cells |
| 09/05/2013 | US20130231293 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
| 09/05/2013 | US20130230600 Therapeutic agent |
| 09/05/2013 | US20130230581 Egfr antagonist for the treatment of heart disease |
| 09/05/2013 | US20130230580 Administration of SNS Neuroprotective Agents to Promote Hematopoietic Regeneration |
| 09/05/2013 | US20130230579 Immunogenic composition comprising neisseria menigitidis macrophage infectivity potentiator protein |
| 09/05/2013 | US20130230578 Lipidated immune response modifier compound compositions, formulations, and methods |
| 09/05/2013 | US20130230558 One dose vaccination against mycoplasma infections of pigs |
| 09/05/2013 | US20130230557 Recombinant microorganisms and uses thereof |
| 09/05/2013 | US20130230556 Herpesvirus of turkeys vectored vaccine against avian influenza in poultry |
| 09/05/2013 | US20130230553 Modulation of immune responses by the poxviral k4 protein |
| 09/05/2013 | US20130230551 Allergy Inhibitor Compositions And Kits And Methods Of Using The Same |
| 09/05/2013 | US20130230550 Methods and compositions involving protective staphylococcal antigens |
| 09/05/2013 | US20130230549 Foot and mouth disease virus with increased stability and its use as vaccine |
| 09/05/2013 | US20130230547 Methods and compositions for prostate cancer immunotherapy |
| 09/05/2013 | US20130230546 Chimeric VEGF Peptides |
| 09/05/2013 | US20130230545 Compounds for treating beta-amyloidoses |
| 09/05/2013 | US20130230541 Anti-igf antibodies |
| 09/05/2013 | US20130230539 Anti-Leukocyte Recruitment Therapy for the Treatment of Seizures and Epilepsy |
| 09/05/2013 | US20130230538 Method of treating a patient having an autoimmune disorder by administering baffr polypeptide |
| 09/05/2013 | US20130230535 Therapy-enhancing glucan |
| 09/05/2013 | US20130230533 Methods of treating systemic lupus erythematosus (sle) using anti-cd48 antibodies |
| 09/05/2013 | US20130230531 Human Antibodies to Clostridium difficile Toxins |
| 09/05/2013 | US20130230530 Human antibodies that bind cd22 and uses thereof |
| 09/05/2013 | US20130230528 Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signaling |
| 09/05/2013 | US20130230527 Emp2 antibodies and their therapeutic uses |
| 09/05/2013 | US20130230526 Klebsiella antigens |
| 09/05/2013 | US20130230523 Methods for detecting th1 cells |
| 09/05/2013 | US20130230522 Complement Pathway Inhibitors Binding To C5 and C5A Without Preventing The Formation of C5B |
| 09/05/2013 | US20130230520 Pharmaceutical composition for treating bone diseases which comprises protein comprising frizzled1, frizzled2 or frizzled7 extracellular cysteine-rich domain |
| 09/05/2013 | US20130230518 Methods for treating sjogrens syndrome by administering a soluble ctla4 molecule |
| 09/05/2013 | US20130230512 Inhibitors of the atb(0,+) transporter and uses thereof |
| 09/05/2013 | US20130230511 Biomarkers for response to tyrosine kinase pathway inhibitors in cancer |
| 09/05/2013 | US20130230510 Method of inhibition of leukemic stem cells |